BTG Share News (BTG)

BTG Information

There is currently no data for BTG

BTG's emphysema treatment struck down by FDA

Thu, 09th Aug 2018 09:04

(Sharecast News) - Global specialist healthcare company BTG on Thursday received confirmation from the US food and drug administration (FDA) that its emphysema treatment will not receive pre-market approval.The company's Elevair Endobronchial Coil System, which was designed to treat patients suffering severe symptoms, had previously failed to receive backing from the FDA's anaesthesiology and respiratory therapy devices panel of the medical devices advisory committee in June.The company had initially reacted by committing to generating clinical data to support its assessment that had "a role to play" in the management of patients with severe emphysema who had few treatment options.But analysts at Peel Hunt said that investors had likely already written off the London-listed company's product for the US market on account of the earlier failing."As such this news will have little impact on estimates or valuation, but might be a small incremental negative for sentiment as it reinforces the difficulty BTG is experiencing in its attempt to pivot the group to interventional medicine amid the decline of its other two more legacy divisions," Peel said.The coils, which are known as PneumRX Coils in Europe, are designed to be permanently implanted in the most emphysema-damaged parts of the lung to allow more efficient contraction that helps assist the breathing cycle.BTG shares were down 1.90% to 515.00p at 0828 BST.

More News

18 May 2018 10:32

WINNERS & LOSERS SUMMARY: Retailer Carpetright Rises On Fundraising

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------DS up 2.1%. to

15 May 2018 12:07

LONDON MARKET MIDDAY: UK Wages In Line But Fail To Inspire Pound

LONDON (Alliance News) - Despite a lower open, the FTSE 100 was trading around its best levels since late January by midday on Tuesday as the latest UK wage data failed to inspire the pound.Rising in

15 May 2018 11:07

BTG Swings To Annual Loss On PneumRx Coils Impairment Charges

LONDON (Alliance News) - BTG PLC on Tuesday swung to a pretax loss for the recently ended financial year due to a large impairment charge relating to PneumRx Coils, used to treat lung disease the

15 May 2018 10:37

WINNERS & LOSERS SUMMARY: Vodafone Stumbles As CEO Stands Down

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 3.3%. The budget airline said it saw a first

15 May 2018 08:32

LONDON MARKET OPEN: easyJet Rises While Vodafone Falls; UK Wages Due

LONDON (Alliance News) - The FTSE 100 was largely unchanged early Tuesday, with easyJet and Vodafone respectively topping and tailing the blue-chip index."In be

8 May 2018 16:09

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 9 May Coca-Cola HBCQ1 ResultsIAGMay Traffic Statistics (at 1500 Year Year 10 11

5 Dec 2016 07:08

BTG product gets two ticks of approval

(ShareCast News) - Global specialist healthcare company BTG announced the inclusion of treatment with its PneumRx Coils product in guidelines for the management of chronic obstructive pulmonary disease on Monday, as published by the Global Initiative for Chronic Obstructive Lung Disease (GOLD). The

16 Nov 2016 09:55

BROKER RATINGS SUMMARY: Goldman And Deutsche Raise Miner Price Targets

15 Nov 2016 10:41

WINNERS & LOSERS SUMMARY: Intermediate Capital And Polypipe Surge

15 Nov 2016 08:13

BTG First Half Profit Slumps Due To Settlement And Currency Impact

15 Nov 2016 07:41

Interventional medicine revenue surges at BTG

(ShareCast News) - Specialist healthcare company BTG posted its interim results for the six months to 30 September on Tuesday, with double-digit revenue growth underpinned by 24% constant exchange rate growth in interventional medicine revenues. The FTSE 250 firm said its operating profit for the pe

1 Nov 2016 10:29

WINNERS & LOSERS SUMMARY: Standard Chartered Sold As Profit Misses

26 Oct 2016 17:40

Wednesday broker round-up

(ShareCast News) - FirstGroup: Goldman Sachs keeps at buy with a target price of 168p. Esure: Berenberg stays at sell, 238p target. Anglo American: Deutsche Bank reiterates hold with a 965p target. Intertek: UBS reiterates buy with a 4100p target. Sainsbury: Goldman Sachs reiterates sell with a 1

26 Oct 2016 08:29

BROKER RATINGS SUMMARY: Goldman Slightly Less Negative On UK Grocers

25 Oct 2016 06:37

Latest Share Chat

BTG Share News (BTG)

BTG's emphysema treatment struck down by FDA

WINNERS & LOSERS SUMMARY: Retailer Carpetright Rises On Fundraising

LONDON MARKET MIDDAY: UK Wages In Line But Fail To Inspire Pound

BTG Swings To Annual Loss On PneumRx Coils Impairment Charges

WINNERS & LOSERS SUMMARY: Vodafone Stumbles As CEO Stands Down

LONDON MARKET OPEN: easyJet Rises While Vodafone Falls; UK Wages Due

UK Earnings, Trading Statements Calendar - Next 7 Days

BTG product gets two ticks of approval

BROKER RATINGS SUMMARY: Goldman And Deutsche Raise Miner Price Targets

WINNERS & LOSERS SUMMARY: Intermediate Capital And Polypipe Surge

BTG First Half Profit Slumps Due To Settlement And Currency Impact

Interventional medicine revenue surges at BTG

WINNERS & LOSERS SUMMARY: Standard Chartered Sold As Profit Misses

Wednesday broker round-up

BROKER RATINGS SUMMARY: Goldman Slightly Less Negative On UK Grocers

Clinigen Group Extends Exclusive Supply Agreement With BTG

Latest Share Chat

BTG Share News (BTG)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BTG's emphysema treatment struck down by FDA

Login to your account

Quickpicks are a member only feature

Login to your account